Biotech · Private company
Kahr Medical
Track this companyFree. Adds Kahr Medical to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AtezolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DSP107Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DSP107Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological MalignanciesPHASE1 · TERMINATED · started Jan 13, 2022ClinicalTrials.gov NCT04937166 · fetched Nov 12, 2026
- A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 7, 2020ClinicalTrials.gov NCT04440735 · fetched Nov 12, 2026